Protocol of a first-in-human clinical trial to evaluate the safety, tolerability, and preliminary efficacy of the bispecific CD276xCD3 antibody CC-3 in patients with colorectal cancer (CoRe_CC-3) - Jung, Susanne Claudia; Schlenk, Richard Friedrich; Hackenbruch, Christopher; Roldan Pinzon, Sandra S. L.; Bitzer, Michael; Pflügler, Martin; Walz, Juliane S.; Jung, Gundram; Heitmann, Jonas S.; Salih, Helmut R. (Frontiers in oncology, 2024)
Gesehen am 15.01.2025